Modeled hCGresist For Risk of Methotrexate Resistance/Failure

For patients with low-risk Gestational Trophoblastic Neoplasias treated with 8-day Methotrexate regimen.

hCGresist is calculated with minimum 4 values of hCG measured during the first 50 days after start of chemotherapy.

Please feel free to share your feedback on this new version with us via email.

In the case of FUNCTIONNAL ISSUE you can use the PREVIOUS VERSION on https://legacy.biomarker-kinetics.org.